DTX1 and gastric cancer: In gastric cancer cells, DTX1 primarily promotes the degradation of cellular FADD-like IL-1β-converting enzyme-inhibitory protein (c-FLIP) in the lysosomal pathway and enhances TNF-related apoptosis-inducing ligand (TRAIL)-induced cell death (Hsu et al., 2018).